Chronic liver congestion progresses to liver fibrosis, eventually leading to cirrhosis and cancer. This study aimed to elucidate the mechanism of congestive hepatopathy (CH), focusing on liver sinusoidal endothelial cells (LSECs).

Intrapancreatic fat deposition (IPFD) is associated with pancreatic diseases, such as pancreatitis, type 2 diabetes mellitus, and pancreatic cancer, and so on. Although non-invasive imaging has been used to quantify IPFD in clinical settings, this approach does not fully reflect the incidence and prevalence of IPFD, especially its occurrence in a cohort of elderly individuals, which is difficult to determine from routine medical visits. This study aims to systematically evaluate IPFD in elderly individuals, classify its subtypes, and assess their relationship with other pancreatic lesions.

About 50% to 75% of patients with Crohn's disease (CD) need bowel resection. Postoperative recurrence of CD is frequent. Here, we investigate the evolution of the mucosa-associated microbiota along the Rutgeerts score measuring endoscopic recurrence after surgery.

Secondary loss of response to ustekinumab is observed in patients with Crohn's disease (CD). Multiple dose-intensification regimens have been proposed. We aimed to test prospectively 2 different dose-intensification regimens with ustekinumab in patients with CD experiencing secondary loss of response.

Despite considerable advancements in recent decades, mortality and complications following liver resection remain high. The volume-outcome relationship has been the subject of extensive research and offers relevant potential for improvement of surgical outcomes. This review aims to examine the impact of hospital and surgeon volume on patient-relevant outcomes in liver resections and synthesize the available evidence.

Irritable Bowel Syndrome (IBS) is a highly prevalent, chronic disorder of the Gut-brain interaction associated with a high healthcare utilization burden. The treatment of IBS remains challenging due to numerous treatment options and heterogeneity in IBS symptoms. Therefore, for effective decision-making, insight into management strategies and treatment preferences of both patients and physicians is important. In our previous study, the most-preferred treatment among IBS patients was dietary intervention, subsequently pharmacotherapy and psychotherapy. However, the preferences of physicians remain unclear.

Glucagon-like peptide-1 (GLP-1) receptor agonists have metabolic and hepatic benefits in metabolic dysfunction–associated steatotic liver disease (MASLD), but their additive benefit compared to lifestyle modification only in real-world settings remains uncertain. This study compared the effects of GLP-1 agonist therapy and physical activity on body mass index (BMI) and noninvasive liver metrics in a predominantly Hispanic clinical population with MASLD.

Patients with familial adenomatous polyposis (FAP) are at increased risk of several gastrointestinal and extraintestinal cancers. Although prophylactic surgery has reduced colorectal cancer (CRC) incidence, the lifetime incidence of other cancers has increased. This study assessed the cumulative risks in Dutch FAP patients over the past decades.

Phosphatidylethanol (PEth) is a direct, objective alcohol biomarker for detecting excessive alcohol use in steatotic liver disease, including metabolic dysfunction and alcohol-associated liver disease (MetALD) and alcohol-associated liver disease (ALD). However, its use in routine clinical practice may be limited by cost and accessibility. This study aimed to develop a novel, accurate, and scalable indirect alcohol biomarker panel to screen for MetALD-ALD in general population settings.

In diagnosing type 1 autoimmune pancreatitis (AIP), serum IgG4 (sIgG4) can be false-negative. EUS-guided fine-needle aspiration/biopsy (EUS-FNA/FNB) pathology is key for diagnosis, but clinical features’ impact on pathologic confirmation is unclear. This study analyzed their link and factors improve diagnostic accuracy.

To understand the heterogeneity of single-B cell responses to Metabolic Dysfunction-Associated Steatohepatitis (MASH), we performed Single-cell RNA sequencing (scRNA-seq) on single-B cells isolated from control and MCD-fed mice livers. Subsequent analyses included clustering, identification of differentially expressed genes (DEGs) and enrichment analysis. The expressions of high specific DEGs were validated using quantitative real-time PCR (qRT-PCR), immunofluorescence staining and function study. Four single-B cell clusters (3, 14, 16 and 20) were identified. The total number and proportion of B cells significantly decreased in MASH mice livers. In cluster 3, the decreasing Fcer2α+ mature B cells were supposed with anti-inflammatory role associated with B cell activation and differentiation of other immune cells in MASH. The DEGs (Fcer2α, Cd22, Cr2 and Fcmr) of cluster 3 were consistently downregulated in B cells cocultued with lipotoxic hepatocytes. And the portal area of livers contained fewer Fcer2α+ B cells in MASH patients and mice compared with controls. Fcer2α+ B cells attenuated lipotoxicity-driven inflammation by enhancing anti-inflammatory factor (IL-10, IL-35) secretion and inhibiting T cell inflammatory factor (IFN-γ, TNF-α, IL-17) production and proliferation. The other 3 clusters (14, 16 and 20) contained small numbers of single-B cell. Tnfrsf17+ plasmacytes (PCs) of cluster 14 were identified with the effect related to endoplasmic reticulum stress and N-Glycan biosynthesis. Klk1+ B cells of cluster 16 were implicated in regulating immune response in MASH. Apol7c+ B cells of cluster 20 participated in apoptosis, NF-κB, TNF and JAK-STAT signaling pathway in MASH. Thus, a subgroup of Fcer2α+ mature B cells, diminished in MASH, may exerted anti-inflammatory or immunosuppressive effects.

Stress-related gastric ulcer (SRGU) is a common complication among critically ill patients, and inappropriate use of stress ulcer prophylaxis (SUP) remains a global challenge in hospitalized populations.

This meta-analysis evaluates the prognostic significance of the Prognostic Nutritional Index (PNI) in colorectal cancer (CRC) patients, focusing on overall survival (OS), disease-free survival (DFS), and progression-free survival (PFS).